360 related articles for article (PubMed ID: 15760652)
1. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease.
Aliyev A; Chen SG; Seyidova D; Smith MA; Perry G; de la Torre J; Aliev G
J Neurol Sci; 2005 Mar; 229-230():285-92. PubMed ID: 15760652
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
3. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice.
Aliev G; Seyidova D; Neal ML; Shi J; Lamb BT; Siedlak SL; Vinters HV; Head E; Perry G; Lamanna JC; Friedland RP; Cotman CW
Ann N Y Acad Sci; 2002 Nov; 977():45-64. PubMed ID: 12480733
[TBL] [Abstract][Full Text] [Related]
4. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer's disease.
Aliev G; Gasimov E; Obrenovich ME; Fischbach K; Shenk JC; Smith MA; Perry G
Vasc Health Risk Manag; 2008; 4(3):721-30. PubMed ID: 18827923
[TBL] [Abstract][Full Text] [Related]
5. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease.
Aliev G; Palacios HH; Walrafen B; Lipsitt AE; Obrenovich ME; Morales L
Int J Biochem Cell Biol; 2009 Oct; 41(10):1989-2004. PubMed ID: 19703659
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease.
Aliev G; Smith MA; de la Torre JC; Perry G
Mitochondrion; 2004 Sep; 4(5-6):649-63. PubMed ID: 16120422
[TBL] [Abstract][Full Text] [Related]
7. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
Reddy PH
J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
[TBL] [Abstract][Full Text] [Related]
8. Regional brain metabolism with cytochrome c oxidase histochemistry in a PS1/A246E mouse model of autosomal dominant Alzheimer's disease: correlations with behavior and oxidative stress.
Strazielle C; Jazi R; Verdier Y; Qian S; Lalonde R
Neurochem Int; 2009 Dec; 55(8):806-14. PubMed ID: 19682525
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease.
Hamel E; Nicolakakis N; Aboulkassim T; Ongali B; Tong XK
Exp Physiol; 2008 Jan; 93(1):116-20. PubMed ID: 17911359
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial dysfunction and Alzheimer's disease.
Maruszak A; Żekanowski C
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):320-30. PubMed ID: 20624441
[TBL] [Abstract][Full Text] [Related]
11. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
Roy S; Rauk A
Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
[TBL] [Abstract][Full Text] [Related]
13. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease.
Anandatheerthavarada HK; Devi L
Neuroscientist; 2007 Dec; 13(6):626-38. PubMed ID: 17911214
[TBL] [Abstract][Full Text] [Related]
14. ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction.
Takuma K; Yao J; Huang J; Xu H; Chen X; Luddy J; Trillat AC; Stern DM; Arancio O; Yan SS
FASEB J; 2005 Apr; 19(6):597-8. PubMed ID: 15665036
[TBL] [Abstract][Full Text] [Related]
15. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice.
Hauptmann S; Scherping I; Dröse S; Brandt U; Schulz KL; Jendrach M; Leuner K; Eckert A; Müller WE
Neurobiol Aging; 2009 Oct; 30(10):1574-86. PubMed ID: 18295378
[TBL] [Abstract][Full Text] [Related]
18. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
[TBL] [Abstract][Full Text] [Related]
19. Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: implications for Alzheimer beta-amyloid pathology.
Maynard CJ; Cappai R; Volitakis I; Cherny RA; Masters CL; Li QX; Bush AI
J Inorg Biochem; 2006 May; 100(5-6):952-62. PubMed ID: 16574231
[TBL] [Abstract][Full Text] [Related]
20. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress.
Lee KW; Kim JB; Seo JS; Kim TK; Im JY; Baek IS; Kim KS; Lee JK; Han PL
J Neurochem; 2009 Jan; 108(1):165-75. PubMed ID: 19012747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
